Moreover, young patients with mutations affecting the ACSF3 gene, diagnosed with combined malonic and methylmalonic acidemia via newborn screening, may present no clinical symptoms or signs indicative of a metabolic disorder at a young age. The gene discussed is ACSF3; the disease is metabolic disease.